Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna Inc    AET

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Aetna Ready For 'Dual Eligibles' Despite Commercial Focus - CFO

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/19/2012 | 09:55pm CET
   By Jon Kamp 
   Of  
 

Aetna Inc. (>> Aetna Inc.) believes it can ably serve health-challenged patients covered by both Medicare and Medicaid, even though the company doesn't have a major stake in those markets.

Additionally, the commercially-focused health insurer doesn't need acquisitions to win business for "dual eligible" patients, according to Chief Financial Officer Joseph Zubretsky. Some of Aetna's big competitors have recently made deals with an eye on dual patients, and Aetna has faced questions about whether it has the right make-up for the market.

"I do believe we'll have the platforms built to be able to respond to this opportunity," Zubretsky said, speaking during an interview at Aetna's Hartford headquarters.

The market has significant potential, but will build over several years, giving Aetna time to grow its businesses from within, Zubretsky said. Meantime, Aetna has the capabilities within these businesses to address the kind of complex health problems dual patients often present, he said.

Dual patients, who represent a potential $300 billion market for health insurers, have become a hot topic as states and the federal government look for ways to better coordinate care and save money. These patients tend to rack up high costs due to their health challenges. A handful of states could have programs for covering dual patients up and running next year, and the market is expected to continue growing in subsequent years.

Managed-care companies could be big beneficiaries, but questions abound about which firms are best positioned to win state-by-state contracts. Analysts view Medicaid-focused insurers such as Molina Healthcare Inc. (>> Molina Healthcare, Inc.) and Centene Corp. (>> Centene Corp) as potential winners, and bigger insurers such as UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) and WellPoint Inc. (WLP) are also expected to compete based on their presence in both the Medicaid and Medicare markets.

Aetna has modest stakes in markets for government-based plans. At the end of last year, roughly 90% of Aetna's 18.5 million medical members were on commercial health plan, which are typically plans provided through employers.

Citigroup analyst Carl McDonald recently said Aetna's valuation has been hurt by "the company's lack of government exposure". Still, Aetna shares are up 33% over the last year, helped by patients keeping a lid on health costs after the recession.

Competitors including UnitedHealth, WellPoint and Cigna Inc. (CI) have all recently made Medicare-focused acquisitions that could improve their chances in the duals market. Aetna has been wary of paying too much, however, and feels there is time to build up its own businesses.

"The opportunity has been reflected in certain managed care valuations long before the revenue is ever going to show up," Zubretsky said. "This is not a cataclysmic event where $300 billion dollars is going to race into the market inside of 12 months. It's going to happen in a phased approach."

Aetna Chief Executive Mark Bertolini has talked about the company's ability to grow its Medicare business by keeping commercial members on Aetna plans when they switch over to Medicare. There are about 1.2 million Medicare-eligible members in the company's commercial membership. He also noted Aetna has more than doubled revenue in its Medicaid business since acquiring it in 2007.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; jon.kamp@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AETNA INC
02:08a Aetna CEO defends merger with Humana in antitrust trial
12/08DJDOJ Questions Aetna-Humana Asset Sale Plan in Court
12/08 INTERPACE DIAGNOSTICS : NetworkNewsBreaks – Interpace Diagnostics (IDXG) S..
12/08 AETNA FOUNDATION : and the National Center for Complex Health and Social Needs T..
12/05DJAetna and Humana Argue a Merger's Benefits as Antitrust Trial Begins
12/05 AETNA : Declares Dividend of $0.2500.
12/02 AETNA : Board of Directors Declares Quarterly Cash Dividend
11/30 AETNA : Premier Care Network Plus Helps Reduce Costs for National Employers and ..
11/23 AETNA : Blue Edge Capital Lowers stake in Aetna Inc
11/22 AETNA INC. (NYSE : AET) Files An 8-K Entry into a Material Definitive Agreement
More news
Sector news : Managed Healthcare - NEC
02:08a Aetna CEO defends merger with Humana in antitrust trial
12/08DJDOJ Questions Aetna-Humana Asset Sale Plan in Court
12/05DJAetna and Humana Argue a Merger's Benefits as Antitrust Trial Begins
11/30DJANTHEM : Begins Defense of Cigna Merger at Antitrust Trial
11/29DJU.S. Stocks Edge Higher
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
12/09 VALUATION DASHBOARD : Healthcare - Update
12/06 Microsoft Defeats Salesforce; LinkedIn Deal Set To Close
12/05 J&J Target Offers Over 20% Upside
12/05 WALL STREET BREAKFAST : Investors Shrug Off Italy's Referendum Result
12/05 DOJ challenges Aetna-Humana deal
Advertisement
Financials ($)
Sales 2016 63 143 M
EBIT 2016 4 909 M
Net income 2016 2 602 M
Debt 2016 4 521 M
Yield 2016 0,77%
P/E ratio 2016 17,71
P/E ratio 2017 15,89
EV / Sales 2016 0,79x
EV / Sales 2017 0,77x
Capitalization 45 235 M
More Financials
Chart AETNA INC
Duration : Period :
Aetna Inc Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Full-screen chart
Technical analysis trends AETNA INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 137 $
Spread / Average Target 6,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC19.23%45 235
UNITEDHEALTH GROUP INC36.11%152 405
ANTHEM INC4.62%38 430
CIGNA CORPORATION-6.29%34 608
HUMANA INC13.88%30 311
CENTENE CORP-13.69%9 707
More Results